Results 221 to 230 of about 38,806 (274)

Immunomodulatory effect of CD71<sup>+</sup> erythroid cells in patients with kidney failure. [PDF]

open access: yesBMC Nephrol
Zamani B   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Erythropoietin and Erythropoietin Receptor

Growth Factors, 1999
(1999). Erythropoietin and Erythropoietin Receptor. Growth Factors: Vol. 17, No. 1, pp. 25-35.
P A, Tilbrook, S P, Klinken
openaire   +2 more sources

The erythropoietin receptor

The International Journal of Biochemistry & Cell Biology, 1999
The erythropoietin (epo) receptor is a member of the cytokine receptor family. It is expressed almost exclusively on erythroid precursor cells and controls the development of red blood cells. The epo receptor has no intrinsic kinase activity, but binds intracellular tyrosine kinases to elicit its signals.
P A, Tilbrook, S P, Klinken
openaire   +2 more sources

Erythropoietin and Erythropoietin Receptor in Colorectal Cancer

International Journal of Surgical Pathology, 2008
Erythropoietin via erythropoietin receptor effectively prevents anemia, giving reasons for a clinical use of erythropoietin in patients with colorectal cancers. However, erythropoietin seems to promote survival of the neoplastic cells in hypoxic environment.
Anna M, Chabowska   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy